BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 4, 2016
View Archived Issues
Amgen and Advaxis enter global collaboration to develop cancer immunotherapies
Read More
Catalent Biologics and Zumutor work together to create antibodies with enhanced ADCC activity
Read More
CYC-065 as a promising new therapy option for resistant/recurrent uterine serous carcinoma
Read More
Genetic variation in COMT modifies effects of clonidine treatment
Read More
Novel bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer
Read More
Merck & Co. develops factor XIa inhibitors
Read More
Boehringer Ingelheim Pharma patents AMPK activators
Read More
Vivreon Biosciences announces calcium activated channel modulators
Read More
Daiichi Sankyo discloses RORgammat antagonists
Read More
Inovio continues to independently develop INO-1800 for the treatment of hepatitis B
Read More
Cellectar Biosciences receives second phase of NCI contract award
Read More
Philogen, Janssen Biotech to collaborate on immunomodulatory therapeutics
Read More
Takeda presents milestones of first quarter of fiscal 2016
Read More
Sanofi reflects on accomplishments of first quarter 2016
Read More
AstraZeneca offers overview of developments in second quarter 2016
Read More
FibroStatin reports promising preclinical results on T-12
Read More
Editas Medicine obtains license to genome-editing technology
Read More
Amicus Therapeutics to submit NDA in Japan for migalastat next year
Read More
Myriad Genetics to acquire Assurex Health
Read More
Santen to collaborate with University College London on ophthalmic research and education
Read More
Sorrento Therapeutics and CHA biotech to form joint venture
Read More
Meiji Seika Pharma outlicenses MS drug candidate to new company
Read More
FDA places partial clinical hold on planned NY-ESO SPEAR T-cell therapy study
Read More
Milestone reached in Evotec, Bayer endometriosis collaboration
Read More